Read our comprehensive list of research and clinical studies conducted with Streptococcus salivarius K12. These studies have shown that regular consumption of BLIS K12™ can effectively promote good oral health by reducing the frequency of recurrent strep throat and otitis media (ear infections) episodes, boosting immunity, and addressing halitosis.
Streptococcus salivarius M18 is an advanced oral probiotic that produces powerful antimicrobial proteins and enzymes, inhibiting the growth of harmful bacteria that cause dental caries, gingivitis, and periodontal diseases. These clinical studies show how daily consumption of BLIS M18™ helps to promotes good dental health by reducing the occurrence of dental caries, gingivitis, and periodontal diseases.
Micrococcus luteus Q24 is a unique probiotic strain developed specifically for improving skin health. Research and development with BLIS Q24™ is in earlier stages than our oral strains, but clinical studies and research to date have demonstrated its safety and efficacy in improving skin health and appearance.